BioTech & SmartPharma
Sector challenges
Sector challenges
The Biotech and SmartPharma sectors continue to develop rapidly. They look set to bring major advances in personalized therapies, early diagnosis, predictive medicine and optimizing the drug value chain – and considerable potential for improving human health and solving complex medical problems.
R&D
Drug Discovery
Biomanufacturing
Technology Platforms
Therapeutic Innovations
Life Science Tools
Performances
BioTech & SmartPharma performance in France in 2022
800
companies
x6
BioTech companies since 2002
3
3 R&D products per BioTech
32
employees on average per company
Our services
Discover how to transform your ambitions into success
Collaboration with WILCO
Companies shaping BioTech & SmartPharma
Your contact
Your contacts at WILCO
Amele Seghaier
Business Manager
Inès Pouradier Duteil
Program Manager
Entrepreneur Mentors
Entrepreneur Mentors for
BioTech & SmartPharma
Yann Barrault
Alain Clergeot
Joël Crouzet
Eric Garnier
